Furthermore, the WT formulation used in our study contained turmerones, which have demonstrated their effectiveness in preventing CRC in mouse models, but these models used CRC, which developed from a background of colitis [29] rather than an inherited mutation in the tumor suppressor gene APC. This evidence concerns the gene APC and colorectal carcinoma.